CTIC Shares Outstanding History



Below is a table of the CTIC shares outstanding history going back to 1/3/2017:

Date CTIC Shares Outstanding
1/3/20170.03B
2/23/201728.23M
4/26/201728.21M
7/27/201742.98M
10/30/201742.97M
2/28/201857.98M
4/26/201857.98M
7/26/201857.99M
10/25/201857.99M
2/28/201957.98M
4/25/201957.98M
7/25/201957.98M
10/24/201957.98M
3/6/202073.68M
4/30/202073.68M
7/30/202073.72M
11/3/202073.75M
3/10/202176.69M
4/29/202193.28M
7/29/202193.31M
10/28/202196.69M
3/17/202299.92M
5/5/2022108.97M
8/1/2022114.39M
10/31/2022126.89M
5/4/2023131.88M

Also see: CTIC Market Cap History
CTIC YTD Return
CTIC Historical Shares Outstanding:
+27.57% CAGR
CTIC Historical Shares Outstanding: +27.57% CAGR

Mouse over chart for data details
1/3/2017 ...5/4/2023
CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies for blood-related cancers where there is an unmet medical need. Co. has one commercially approved product, VONJO™ (pacritinib), which has received approval in the U.S. by the U.S. Food and Drug Administration for the treatment of adult patients with intermediate or primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis with a platelet count below 50 x 10^9/L. We show 26 historical shares outstanding datapoints in our coverage of CTIC's shares outstanding history.

Understanding the changing numbers of CTIC shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CTIC versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CTIC by allowing them to research CTIC shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree CTIC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
CTI BioPharma (CTIC) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

CTKB Shares Outstanding History
CTLT Shares Outstanding History
CTMX Shares Outstanding History
CTNM Shares Outstanding History
CTRV Shares Outstanding History
CTSO Shares Outstanding History
CTXR Shares Outstanding History
CUE Shares Outstanding History
CUR Shares Outstanding History
CUTR Shares Outstanding History
More Healthcare companies »

 

CTIC Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2025, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.